Expert Review of Vaccines is converting to Open Access
Expert Review of Vaccines is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed research in the development, application, and clinical effectiveness of new vaccines.
The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.
We have listened to the needs of the research community in this area and that is why we’re pleased to announce the journal will be moving to an Open Access model. By making Expert Review of Vaccines open access, research published in the journal will be available to the widest possible audience and therefore can make a greater contribution to the vaccine research community. Beginning 26th July 2022, all manuscripts submitted to the journal will, if accepted, be required to pay an article publishing charge (APC) which can be covered by an author’s funder or institution. We look forward to receiving your submissions and welcome your support in this exciting new open access chapter for the journal. Use the Open Access cost finder to find information on APC fees.
The journal features cutting edge reviews and original articles on vaccines, the immune response, and the powerful impact of immunization against infectious diseases. We also cover vaccine technologies and platforms, adjuvants, therapeutic vaccines and vaccination for the control of non-communicable diseases.
Alongside review articles, the journal welcomes clinically relevant and novel original research. Pharmacoeconomic studies are considered if there is clear clinical relevance. Please note that the journal does not publish case reports or animal studies. Letters to the Editor should discuss articles previously published in the journal.